Literature DB >> 18821081

Dopamine dysregulation syndrome. Hypothetical application of reward system stimulation for the treatment of anhedonia in Parkinson's disease patients.

Tomoyoshi Kondo1.   

Abstract

The management of motor symptoms in Parkinson's disease (PD), although imperfect, has already been standardized. However, patients often spend their time idly despite improvement in the elemental motor symptoms. The main cause of this may be anhedonia. Dopamine dysregulation syndrome (DDS) is a troublesome condition that can occur as a complication of dopamine replacement therapy in PD. As anhedonia and DDS may be converse syndromes in PD patients, it is very important to overcome anhedonia to improve patients' quality of life. In this article, the author proposes the possibility of stimulating patients' desire to participate in physical activity via the incentive of a reward system. Understanding the mechanism of DDS may help in the development of this type of approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821081     DOI: 10.1007/s00415-008-4003-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

2.  Decision-making impairments in patients with pathological gambling.

Authors:  Matthias Brand; Elke Kalbe; Kirsten Labudda; Esther Fujiwara; Josef Kessler; Hans J Markowitsch
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

3.  Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.

Authors:  Matthias R Lemke; H Michael Brecht; Juergen Koester; Heinz Reichmann
Journal:  J Neurol Sci       Date:  2006-06-30       Impact factor: 3.181

4.  Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task.

Authors:  Mutsutaka Kobayakawa; Shinichi Koyama; Masaru Mimura; Mitsuru Kawamura
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

5.  The Reward Signal of Midbrain Dopamine Neurons.

Authors:  Wolfram Schultz
Journal:  News Physiol Sci       Date:  1999-12

6.  Clinical features associated with impulse control disorders in Parkinson disease.

Authors:  Gregory Pontone; James R Williams; Susan Spear Bassett; Laur Marsh
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

7.  The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.

Authors:  K Nakamura; M Ahmed; E Barr; J M Leiden; U J Kang
Journal:  Cell Transplant       Date:  2000 Sep-Oct       Impact factor: 4.064

8.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

9.  Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Authors:  Valerie Voon; Teri Thomsen; Janis M Miyasaki; Minella de Souza; Ariel Shafro; Susan H Fox; Sarah Duff-Canning; Anthony E Lang; Mateusz Zurowski
Journal:  Arch Neurol       Date:  2007-02

10.  Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement.

Authors:  Jeffrey W Dalley; Tim D Fryer; Laurent Brichard; Emma S J Robinson; David E H Theobald; Kristjan Lääne; Yolanda Peña; Emily R Murphy; Yasmene Shah; Katrin Probst; Irina Abakumova; Franklin I Aigbirhio; Hugh K Richards; Young Hong; Jean-Claude Baron; Barry J Everitt; Trevor W Robbins
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

View more
  2 in total

1.  MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Authors:  Mauricio P Cunha; Francis L Pazini; Vicente Lieberknecht; Josiane Budni; Ágatha Oliveira; Júlia M Rosa; Gianni Mancini; Leidiane Mazzardo; André R Colla; Marina C Leite; Adair R S Santos; Daniel F Martins; Andreza F de Bem; Carlos Alberto S Gonçalves; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

2.  Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.

Authors:  Perla Ugalde-Muñiz; Ingrid Fetter-Pruneda; Luz Navarro; Esperanza García; Anahí Chavarría
Journal:  Oxid Med Cell Longev       Date:  2020-01-13       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.